IL17RC and acute lymphoblastic leukemia: Investigating the genetic and molecular irregularities that precipitate the onset and advancement of ALL, such as alterations in the IL‐17RC gene and its influence on cytokine signalling pathways, holds the promise of advancing personalized medicine.